Unmasking hidden high risk in RUNX1::RUNX1T1 pediatric AML: Development of a novel prognostic model
{{output}}
Although pediatric acute myeloid leukemia (pAML) harboring the RUNX1::RUNX1T1 fusion is generally classified as favorable risk, some patients experience poor outcomes. To address this heterogeneity, we developed and validated a prognostic model to refine risk ... ...
